Guanze Medical Information Industry (Holding) Co (HKSE:02427) Operating Income: HK$-70.88 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:02427 Guanze Medical Information Industry (Holding) Co Ltd HKSE:02427
52 GF Score
Price HK$2.65
GF Value HK$0.27
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Guanze Medical Information Industry (Holding) Co Operating Income?

Guanze Medical Information Industry (Holding) Co HKSE:02427 +10.88% 52 Operating Income is HK$-70.88 Mil as of Dec. 2025. GuruFocus rates HKSE:02427 with a GF Score™ of 52/100 and a GF Value™ of HK$0.27 (Significantly Overvalued). The stock has 4 warning signs investors should review.

Guanze Medical Information Industry (Holding) Co's Operating Income for the six months ended in Dec. 2025 was HK$-23.37 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Dec. 2025 was HK$-70.88 Mil.

Operating Margin % is calculated as Operating Income divided by its Revenue. Guanze Medical Information Industry (Holding) Co's Operating Income for the six months ended in Dec. 2025 was HK$-23.37 Mil. Guanze Medical Information Industry (Holding) Co's Revenue for the six months ended in Dec. 2025 was HK$62.52 Mil. Therefore, Guanze Medical Information Industry (Holding) Co's Operating Margin % for the quarter that ended in Dec. 2025 was -37.38%.

Guanze Medical Information Industry (Holding) Co's 5-Year average Growth Rate for Operating Margin % was 0.00% per year.

Operating Income or EBIT is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Guanze Medical Information Industry (Holding) Co's annualized ROC % for the quarter that ended in Dec. 2025 was -16.80%. Guanze Medical Information Industry (Holding) Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was -32.35%.


Guanze Medical Information Industry (Holding) Co  (HKSE:02427) Operating Income Explanation

1. Operating Income or EBIT is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Guanze Medical Information Industry (Holding) Co's annualized ROC % for the quarter that ended in Dec. 2025 is calculated as:

ROC % (Q: Dec. 2025 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Jun. 2025 ) + Invested Capital (Q: Dec. 2025 ))/ count )
=-46.736 * ( 1 - 7.07% )/( (269.311 + 247.596)/ 2 )
=-43.4317648/258.4535
=-16.80 %

where

Note: The Operating Income data used here is two times the semi-annual (Dec. 2025) data.

2. Joel Greenblatt's definition of Return on Capital:

Guanze Medical Information Industry (Holding) Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 is calculated as:

ROC (Joel Greenblatt) %(Q: Dec. 2025 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Jun. 2025  Q: Dec. 2025
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-78.92/( ( (71.583 + max(184.086, 0)) + (54.266 + max(177.944, 0)) )/ 2 )
=-78.92/( ( 255.669 + 232.21 )/ 2 )
=-78.92/243.9395
=-32.35 %

where Working Capital is:

Working Capital(Q: Jun. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(151.217 + 25.98 + 34.544) - (27.008 + 0 + 0.64700000000001)
=184.086

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(175.026 + 8.136 + 22.508) - (27.212 + 0 + 0.514)
=177.944

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Dec. 2025) EBIT data.

3. Operating Income is also linked to Operating Margin %:

Guanze Medical Information Industry (Holding) Co's Operating Margin % for the quarter that ended in Dec. 2025 is calculated as:

Operating Margin %=Operating Income (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=-23.368/62.519
=-37.38 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

4. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Operating Income growth rate using Operating Income per share data.


Be Aware

Compared with a company's EBITDA margin, Operating Margin can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin may decline. Often the Operating Margin declines well before the company's revenue or even profit decline. Therefore, Operating Margin is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia's Operating Margin had already been in decline since 2002, although its earnings per share were still rising. Investors who paid attention to Operating Margin would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


Guanze Medical Information Industry (Holding) Co Operating Income Related Terms


Guanze Medical Information Industry (Holding) Co Operating Income Historical Data

* Premium members only.

The historical data trend for Guanze Medical Information Industry (Holding) Co's Operating Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Guanze Medical Information Industry (Holding) Co Operating Income Chart

Guanze Medical Information Industry (Holding) Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Operating Income
Get a 7-Day Free Trial 41.17 34.45 43.98 33.63 -16.96

Guanze Medical Information Industry (Holding) Co Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Operating Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.23 29.44 6.34 -23.37 -47.52
HKSE:02427
52GF Score
Guanze Medical Information Industry (Holding) Co Ltd HKSE:02427
Operating Income is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Guanze Medical Information Industry (Holding) Co Operating Income Calculation

Operating Income, is the profit a company earned through operations. All expenses, including cash expenses such as cost of goods sold (COGS), research & development, wages, and non-cash expenses, such as depreciation, depletion and amortization, have been deducted from the sales.

Operating Income for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$-70.88 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Operating Income →
What does a Operating Income of HK$-70.88 Mil mean?
Guanze Medical Information Industry (Holding) Co (HKSE:02427) has a Operating Income of HK$-70.88 Mil as of Dec. 2025. Operating Income equals sales less all operating expenses. It is linked to EBIT. View historical data on Guanze Medical Information Industry (Holding) Co and its competitors.
Is Guanze Medical Information Industry (Holding) Co's Operating Income too high?
Guanze Medical Information Industry (Holding) Co's current Operating Income is HK$-70.88 Mil. Overall, Guanze Medical Information Industry (Holding) Co has a GF Score™ of 52/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Guanze Medical Information Industry (Holding) Co's Operating Income compare to TMO and DHR?
Guanze Medical Information Industry (Holding) Co's Operating Income of HK$-70.88 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Income for a Medical Distribution company?
A good Operating Income depends on the Medical Distribution industry context. However, Operating Income should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Income mean?
A high Operating Income can signal that a stock is expensive relative to its fundamentals. Operating Income equals sales less all operating expenses. It is linked to EBIT. View historical data on Guanze Medical Information Industry (Holding) Co and its competitors. Guanze Medical Information Industry (Holding) Co's current Operating Income is HK$-70.88 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Guanze Medical Information Industry (Holding) Co stock overvalued right now?
Based on GuruFocus' analysis, Guanze Medical Information Industry (Holding) Co (HKSE:02427) is currently considered Significantly Overvalued. The stock's GF Value™ is HK$0.27, compared to a current price of HK$2.65 — trading 881.5% above its estimated fair value. The current Operating Income is HK$-70.88 Mil. Guanze Medical Information Industry (Holding) Co's overall GF Score™ is 52/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Income calculated?
Operating Income is calculated from a company's financial statements. For Guanze Medical Information Industry (Holding) Co (HKSE:02427), the current Operating Income is HK$-70.88 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Guanze Medical Information Industry (Holding) Co (HKSE:02427) Overvalued in 2026?

Based on GuruFocus' analysis, Guanze Medical Information Industry (Holding) Co stock appears to be overvalued. The current stock price of HK$2.65 is trading 881.5% above its estimated GF Value™ of HK$0.27. GuruFocus considers Guanze Medical Information Industry (Holding) Co to be Significantly Overvalued.

Key valuation signals for HKSE:02427:

  • Operating Income: HK$-70.88 Mil
  • GF Value™: HK$0.27 vs. price of HK$2.65 (881.5% above fair value)
  • GF Score™: 52/100 with 4 warning signs

No single metric tells the full story. See the HKSE:02427 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Guanze Medical Information Industry (Holding) Co Business Description

Address No. 2966 Chunhui Road, Room 501-A, Block 10 Strategic Emerging Industry Base, Jinan High-tech Zone, Shandong Province, Jinan, CHN
Guanze Medical Information Industry (Holding) Co Ltd is a medical imaging solutions provider, principally engaged in providing medical imaging film products and medical imaging cloud services in Shandong Province. The company generates the majority of its revenue from the PRC.
52GF Score

Get the complete analysis for HKSE:02427

Operating Income is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$2.65
Price
HK$0.27
GF Value